Globe Life (NYSE:GL) Reaches New 52-Week High - Here's Why

Key Points

• Globe Life hit a new 52-week high intraday at $156.69 (last $156.21), with a market cap of about $12.11 billion and a P/E of ~10.7.
• Wall Street is largely bullish: the consensus rating is Buy with an average price target of $172.67, and multiple firms (JPMorgan, Wells Fargo, Keefe) recently raised or reaffirmed Buy/Overweight ratings.
• Q1 EPS of $3.43 missed estimates by $0.03 while revenue rose 5.3% to $1.56B; management set FY2026 EPS guidance of 15.40–15.90 (analysts expect 15.53) and declared a $0.33 quarterly dividend, though insiders sold roughly 121,470 shares (~$18M) in the last three months.

Globe Life Inc. (NYSE:GL - Get Free Report)'s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $156.69 and last traded at $156.21, with a volume of 12021 shares changing hands. The stock had previously closed at $154.14.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on GL shares. JPMorgan Chase & Co. raised their price objective on shares of Globe Life from $180.00 to $181.00 and gave the stock an "overweight" rating in a research note on Thursday, February 5th. Keefe, Bruyette & Woods reaffirmed a "moderate buy" rating and set a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Wells Fargo & Company increased their price target on Globe Life from $171.00 to $172.00 and gave the stock an "overweight" rating in a report on Friday, April 10th. Weiss Ratings lowered Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a research note on Monday, April 27th. Finally, Texas Capital upgraded Globe Life to a "strong-buy" rating in a report on Wednesday, March 18th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $172.67.

Globe Life Price Performance

The firm has a market capitalization of $12.11 billion, a P/E ratio of 10.67 and a beta of 0.50. The stock's 50 day simple moving average is $144.52 and its 200 day simple moving average is $140.12. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 21.30%. The firm had revenue of $1.56 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the previous year, the firm posted $3.07 EPS. The firm's revenue for the quarter was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, analysts expect that Globe Life Inc. will post 15.53 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. Globe Life's dividend payout ratio is presently 9.13%.

Insider Transactions at Globe Life

In other news, EVP Michael Clay Majors sold 34,000 shares of the company's stock in a transaction that occurred on Friday, April 24th. The shares were sold at an average price of $153.81, for a total value of $5,229,540.00. Following the completion of the sale, the executive vice president owned 53,518 shares of the company's stock, valued at approximately $8,231,603.58. This represents a 38.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the transaction, the chief marketing officer directly owned 17,479 shares in the company, valued at approximately $2,501,944.06. The trade was a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 121,470 shares of company stock valued at $17,988,368 over the last three months. 2.11% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Bessemer Group Inc. boosted its position in Globe Life by 4.9% during the first quarter. Bessemer Group Inc. now owns 2,656 shares of the company's stock valued at $368,000 after purchasing an additional 124 shares in the last quarter. SteelPeak Wealth LLC lifted its position in shares of Globe Life by 34.8% during the first quarter. SteelPeak Wealth LLC now owns 26,069 shares of the company's stock valued at $3,628,000 after buying an additional 6,736 shares during the last quarter. Illinois Municipal Retirement Fund boosted its holdings in shares of Globe Life by 4.4% in the 1st quarter. Illinois Municipal Retirement Fund now owns 46,856 shares of the company's stock valued at $6,521,000 after buying an additional 1,969 shares in the last quarter. Advisors Preferred LLC purchased a new position in shares of Globe Life in the 1st quarter worth approximately $521,000. Finally, Hillsdale Investment Management Inc. grew its position in shares of Globe Life by 17.9% in the 1st quarter. Hillsdale Investment Management Inc. now owns 10,550 shares of the company's stock worth $1,468,000 after buying an additional 1,600 shares during the last quarter. 81.61% of the stock is owned by institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.